Global Gastrointestinal Drug Market to 2022 - Pipeline Characterized by Emerging Biologic Therapies, While TNF Inhibitors and PPIs Continue to Dominate Therapy Landscape
4541 4995 3860
- Executive Summary
- 4.3 Molecular Targets in the Pipeline
Gastrointestinal morbidity in obesity.
The gut is especially vulnerable to tension and can demonstrate stress-induced physiological changes causing gastrointestinal discomfort.